Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9NCC
|
||||
| Drug Name |
(S)-1-(4-(4-methoxybenzo[b]thiophen-2-yl)piperidin-1-yl)-3-(2-methyl-1H-indol-4-yloxy)propan-2-ol
|
||||
| Synonyms |
CHEMBL300340
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30N2O3S
|
||||
| Canonical SMILES |
COc1cccc2sc(cc12)C3CCN(C[C@H](O)COc4cccc5[nH]c(C)cc45)CC3
|
||||
| InChI |
InChI=1S/C26H30N2O3S/c1-17-13-20-22(27-17)5-3-7-24(20)31-16-19(29)15-28-11-9-18(10-12-28)26-14-21-23(30-2)6-4-8-25(21)32-26/h3-8,13-14,18-19,27,29H,9-12,15-16H2,1-2H3/t19-/m0/s1
|
||||
| InChIKey |
SYWVBRYJGFTBHV-IBGZPJMESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.